81
Views
1
CrossRef citations to date
0
Altmetric
Letter

Incidence of transient single metaphase chromosomal abnormalities identified by routine metaphase cytogenetics in bone marrow specimens

&
Pages 2080-2082 | Received 27 Jan 2012, Accepted 18 Mar 2012, Published online: 23 Apr 2012

References

  • Robbins WA, Meistrich ML, Moore D, . Chemotherapy induces transient sex chromosomal and autosomal aneuploidy in human sperm. Nat Genet 1997;16:74–78.
  • Mrozek K, Heerema NA, and Bloomfield CD. Cytogenetics in acute leukemia. Blood Rev 2004;18:115–136.
  • Kim M, Lee S, Jung CK, . Transient trisomy 8 abnormality in Philadelphia-negative cells during imatinib mesylate treatment of chronic myelogenous leukemia. Int J Lab Hematol 2008;30: 508–512.
  • Kasprzyk A, Mehta AB, and Secker-Walker LM. Single-cell trisomy in hematologic malignancy. Cancer Genet Cytogenet 1995; 85:37–42.
  • ISCN rules for listing chromosomal rearrangements. Curr Protoc Hum Genet 1998:A.4C.1–A.4C.55.
  • Jabbour E, Kantarjian HM, Abruzzo LV, . Chromosomal abnormalities in Philadelphia chromosome-negative metaphases appearing during imatinib mesylate therapy in patients with newly diagnosed chronic myeloid leukemia in chronic phase. Blood 2007;110:2991–2995.
  • Basecke J, Podleschny M, Becker A, . Therapy-associated genetic aberrations in patients treated for non-Hodgkin lymphoma. Br J Haematol 2008;141:52–59.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.